GE HealthCare Stock Dips Amidst Mixed Q2 Earnings Outlook

GE HealthCare Technologies Inc. (GEHC), based in Chicago, is poised to report its second-quarter earnings. Analysts anticipate a 1.9% decrease in diluted EPS for Q2 2026, falling to $1.04 from $1.06 year-over-year. However, GEHC has a track record of surpassing earnings expectations in three of the last four quarters.

The company recently launched Allia upgrade pathways, enabling hospitals to modernize interventional imaging systems without significant infrastructure changes. These AI-powered upgrades are designed to enhance imaging, streamline workflow, and improve connectivity, thereby cutting costs and extending equipment lifespan.

Despite a 13.9% stock decline over the past 52 weeks, analysts maintain a favorable outlook. The stock holds a 'Moderate Buy' consensus, with an average price target suggesting a 21.6% potential upside. GEHC also declared a cash dividend of $0.035 per share for the second quarter, payable on August 14, 2026.